FDA PDUFA dates in November 2026
Published PDUFA target action dates for NDAs, BLAs, ANDAs, and INDs scheduled in November 2026, sourced from FDA primary records.
Tracking 15 published FDA PDUFA decisions, including 11 NDAs and 4 BLAs.
| Sponsor | Product | Type | Application | PDUFA date | Status | Ask, copy and expand |
|---|---|---|---|---|---|---|
| Agios Pharmaceuticals | mitapivat | NDA | PENDING-provisional|agiospharmaceuticals|mitapivat|sickl | overdue | ||
| Cytokinetics | MYQORZO (aficamten) | NDA | PENDING-provisional|cytokinetics|myqorzoaficamten|obstru | upcoming | ||
| BioXcel Therapeutics | IGALMI | NDA | PENDING-provisional|bioxceltherapeutics|igalmi|acutetrea | upcoming | ||
| Summit Therapeutics | ivonescimab + chemotherapy | BLA | PENDING-provisional|summittherapeutics|ivonescimabchemot | upcoming | ||
| Beren Therapeutics | adrabetadex | NDA | PENDING-provisional|berentherapeutics|adrabetadex|infant | upcoming | ||
| Savara | molgramostim | BLA | PENDING-provisional|savara|molgramostim|autoimmunepulmon | upcoming | ||
| Capricor Therapeutics | deramiocel | BLA | PENDING-provisional|capricortherapeutics|deramiocel|duch | upcoming | ||
| Sanofi | venglustat | NDA | PENDING-provisional|sanofi|venglustat|type3gaucherdiseas | upcoming | ||
| BridgeBio Pharma | BBP-418 | NDA | PENDING-provisional|bridgebiopharma|bbp418|limbgirdlemus | upcoming | ||
| Zydus Therapeutics | saroglitazar | NDA | PENDING-provisional|zydustherapeutics|saroglitazar|prima | upcoming | ||
| Nuvalent | neladalkib | NDA | PENDING-provisional|nuvalent|neladalkib|tkipretreatedadv | upcoming | ||
| PolyPid | D-PLEX100 | NDA | PENDING-provisional|polypid|dplex100|preventionofsurgica | upcoming | ||
| Vertex Pharmaceuticals | povetacicept | BLA | PENDING-provisional|vertexpharmaceuticals|povetacicept|a | upcoming | ||
| Genentech (Roche) | giredestrant | NDA | PENDING-provisional|genentechroche|giredestrant|adjuvant | upcoming | ||
| Cogent Biosciences | bezuclastinib + sunitinib | NDA | PENDING-provisional|cogentbiosciences|bezuclastinibsunit | upcoming |
Select any row to expand its full record. Use the calendar, timeline, status board, or table views above to filter, sort, and inspect source-linked details.
November 2026 FDA PDUFA Calendar: Drug Approval Dates & Deadlines
Track November 2026 FDA review dates and drug approval decisions. Browse products, sponsors, application types, source-linked deadlines, and reported outcomes.
Loading calendar controls…
